Search - tctmd.com

Displaying 81 - 100 of 602

Sort: Relevancy | Date

Presentation TCT 2023

TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium

Presenter: Seong Huan Choi

October 25, 2023

Presentation TCT 2023

TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

Presenter: Byeong-Keuk Kim

October 25, 2023

Presentation TCT 2023

Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Drug-Eluting Stent In-Stent Restenosis: A Prospective, Multicenter, Randomized Trial

Presenter: Shao-Liang Chen

October 25, 2023

Presentation TCT 2023

Less Than 1-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: A Randomized Trial

Presenter: Myeong-Ki Hong

October 25, 2023

Presentation TCT 2023

TCT 649: Impact of a Novel Hybrid Nano-coated Nitinol Drug-eluting Stent (Hybrid-DES) on Below-the-knee Atherosclerotic Disease: 2023 Update

Presenter: Terumitsu Hasebe

October 25, 2023

Presentation TCT 2023

TCT 565: Drug-Coated Versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated With Provisional Stenting Using Drug-Eluting Stents: Randomized Study

Presenter: MEFTAH Abdelouahed

October 25, 2023

Presentation TCT 2023

First Human Use of a ‘Hybrid’ (Polymer + Metal) Coronary Drug-Eluting Stent: The IonMAN Study

Presenter: Alexandre Abizaid

October 25, 2023

Presentation TCT 2023

TCT 1007: What lesion would you do first/what is the culprit artery ? - Is Drug Eluting Balloon, good as stents?

Presenter: Thisara Samarawickrama

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Presentation TCT 2023

TCT 811: Drug Eluting Balloon for Early Aggressive Neointimal Hyperplasia for Coronary Artery In-Stent Restenosis

Presenter: Parth Parikh

October 24, 2023

Presentation TCT 2023

TCT 527: Changes of the Protruded Plaque After Drug Eluting Stent Implantation in Patients with Acute Coronary Syndrome Evaluated With Optical Coherence Tomography

Presenter: Yuki Aoki

October 24, 2023

Presentation TCT 2023

R3 Vascular MAGNITUDE Bioresorbable Drug Eluting Scaffold

Presenter: Juan Granada

October 24, 2023

Presentation TCT 2023

TCT 229: Effect of delayed hospitalization on patients with non-ST-segment elevation myocardial infarction and complex lesions undergoing successful new-generation drug-eluting stents implantation

Presenter: Yong Hoon Kim

October 24, 2023

Presentation TCT 2023

Cre8 Amphilimus Drug-Eluting Stent

Presenter: Rafael Romaguera

October 24, 2023

Presentation TCT 2023

TCT 351: Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion, 10-year Extended Follow-up Results

Presenter: Seung-Whan Lee

October 24, 2023

Presentation TCT 2023

TCT 226: Impact of Platelet Reactivity on Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients according to the Presence or Absence of Chronic Total Occlusion: Analysis from PTRG-DES Registry

Presenter: Donghoon Han

October 24, 2023

Presentation TCT 2023

TCT 74: Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With In-stent Restenosis in Small Coronary Arteries.

Presenter: Wojciech Wanha

October 24, 2023

Presentation TCT 2023

TCT 60: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis in Chronic Coronary Syndrome (CCS Dragon-Registry)

Presenter: Wojciech Wanha

October 24, 2023

Presentation TCT 2022

Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial

Presenter: Pablo Salinas

September 19, 2022

Presentation TCT 2022

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Presenter: Jonas Haener

September 19, 2022

Advertisement

TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium

TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Drug-Eluting Stent In-Stent Restenosis: A Prospective, Multicenter, Randomized Trial

Less Than 1-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: A Randomized Trial

TCT 649: Impact of a Novel Hybrid Nano-coated Nitinol Drug-eluting Stent (Hybrid-DES) on Below-the-knee Atherosclerotic Disease: 2023 Update

TCT 565: Drug-Coated Versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated With Provisional Stenting Using Drug-Eluting Stents: Randomized Study

First Human Use of a ‘Hybrid’ (Polymer + Metal) Coronary Drug-Eluting Stent: The IonMAN Study

TCT 1007: What lesion would you do first/what is the culprit artery ? - Is Drug Eluting Balloon, good as stents?

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

TCT 811: Drug Eluting Balloon for Early Aggressive Neointimal Hyperplasia for Coronary Artery In-Stent Restenosis

TCT 527: Changes of the Protruded Plaque After Drug Eluting Stent Implantation in Patients with Acute Coronary Syndrome Evaluated With Optical Coherence Tomography

R3 Vascular MAGNITUDE Bioresorbable Drug Eluting Scaffold

TCT 229: Effect of delayed hospitalization on patients with non-ST-segment elevation myocardial infarction and complex lesions undergoing successful new-generation drug-eluting stents implantation

Cre8 Amphilimus Drug-Eluting Stent

TCT 351: Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion, 10-year Extended Follow-up Results

TCT 226: Impact of Platelet Reactivity on Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients according to the Presence or Absence of Chronic Total Occlusion: Analysis from PTRG-DES Registry

TCT 74: Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With In-stent Restenosis in Small Coronary Arteries.

TCT 60: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis in Chronic Coronary Syndrome (CCS Dragon-Registry)

Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content